Implementation of a Radioreceptor Assay for Dexmedetomidine

: We have implemented a radioreceptor assay for dexmedetomidine, a novel α2‐adrenoceptor agonist. Receptor‐bearing membranes were prepared from rat cerebral cortex and 3H‐clonidine, 4 nM, was used as the labeled ligand. Dexmedetomidine displaced 3H‐clonidine in a linear fashion over a concentration...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacology & toxicology 1993-11, Vol.73 (5), p.254-256
Hauptverfasser: Salonen, Markku, Maze, Mervyn
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 256
container_issue 5
container_start_page 254
container_title Pharmacology & toxicology
container_volume 73
creator Salonen, Markku
Maze, Mervyn
description : We have implemented a radioreceptor assay for dexmedetomidine, a novel α2‐adrenoceptor agonist. Receptor‐bearing membranes were prepared from rat cerebral cortex and 3H‐clonidine, 4 nM, was used as the labeled ligand. Dexmedetomidine displaced 3H‐clonidine in a linear fashion over a concentration of 2 × 10‐10 to 2 × 10‐8 M. The detection limit of dexmedetomidine (i.e. 10% of radiolabeled ligand displaced) in this assay was 50 pg.ml‐1 which is comparable to that seen with the reference method which utilizes gas chromotography with mass spectrometer (GC/MS) in series (Vuorilehto et al. 1989). Endogenous catecholamines, which can displace the radiolabeled ligand from its binding site, could easily be eliminated with a one‐step extraction procedure. A comparison was made with the reference method (GC/MS) in 47 human plasma samples; the correlation coefficient (r2) was 0.61 (P
doi_str_mv 10.1111/j.1600-0773.1993.tb00580.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76241551</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76241551</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3990-b3859fb034843ad820f7bc3fc4ed8f4662bcb21bb3b8e6f3885497572810f7b53</originalsourceid><addsrcrecordid>eNqVkF1LwzAUhoMoc8z9BKGIeNeaNE2T6IXM-TUYKDKvQ5ImEOmXTYfbvzdlZffmJgfe5-ScPABcIZigcG6_E5RDGENKcYI4x0mvICQMJrsTMD1Gp2AKOUQx5yk7B3PvnYKYUIZQlk_AhHKYM8qn4H5VtaWpTN3L3jV11NhIRp-ycE1ntGn7posW3st9ZEP1ZHaVKUzfVK5wtbkAZ1aW3szHewa-Xp43y7d4_f66Wi7Wscacw1hhRrgN4zOWYVmwFFqqNLY6MwWzWZ6nSqsUKYUVM7nFjJGMU0JThgaS4Bm4Obzbds3P1vheVM5rU5ayNs3WC5qnGSIEBfDuAOqu8b4zVrSdq2S3FwiKQZ74FoMhMRgSgzwxyhO70Hw5Ttmq8Mtj66gq5NdjLr2Wpe1krZ0_YpjRHJIsYA8H7NeVZv-PBcTj8mMTKvwHvwCLKw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76241551</pqid></control><display><type>article</type><title>Implementation of a Radioreceptor Assay for Dexmedetomidine</title><source>MEDLINE</source><source>Wiley Journals Collection</source><creator>Salonen, Markku ; Maze, Mervyn</creator><creatorcontrib>Salonen, Markku ; Maze, Mervyn</creatorcontrib><description>: We have implemented a radioreceptor assay for dexmedetomidine, a novel α2‐adrenoceptor agonist. Receptor‐bearing membranes were prepared from rat cerebral cortex and 3H‐clonidine, 4 nM, was used as the labeled ligand. Dexmedetomidine displaced 3H‐clonidine in a linear fashion over a concentration of 2 × 10‐10 to 2 × 10‐8 M. The detection limit of dexmedetomidine (i.e. 10% of radiolabeled ligand displaced) in this assay was 50 pg.ml‐1 which is comparable to that seen with the reference method which utilizes gas chromotography with mass spectrometer (GC/MS) in series (Vuorilehto et al. 1989). Endogenous catecholamines, which can displace the radiolabeled ligand from its binding site, could easily be eliminated with a one‐step extraction procedure. A comparison was made with the reference method (GC/MS) in 47 human plasma samples; the correlation coefficient (r2) was 0.61 (P&lt;0.001). The radioreceptor assay was also successfully applied for determining dexmedetomidine concentration in rabbit samples. These data indicate that the radioreceptor assay can be utilized for characterizing the pharmacokinetics of novel α2 agonists which are now being introduced into the clinical practice of anaesthesia.</description><identifier>ISSN: 0901-9928</identifier><identifier>EISSN: 1600-0773</identifier><identifier>DOI: 10.1111/j.1600-0773.1993.tb00580.x</identifier><identifier>PMID: 7906879</identifier><identifier>CODEN: PHTOEH</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adrenergic alpha-Agonists - analysis ; Adrenergic alpha-Agonists - metabolism ; Analysis ; Animals ; Biological and medical sciences ; Cerebral Cortex - metabolism ; Clonidine - metabolism ; General pharmacology ; Imidazoles - analysis ; Imidazoles - metabolism ; Male ; Medetomidine ; Medical sciences ; Pharmacology. Drug treatments ; Rabbits ; Radioligand Assay - methods ; Rats ; Rats, Sprague-Dawley ; Receptors, Adrenergic, alpha - metabolism</subject><ispartof>Pharmacology &amp; toxicology, 1993-11, Vol.73 (5), p.254-256</ispartof><rights>1993 Nordic Pharmacological Society</rights><rights>1994 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3990-b3859fb034843ad820f7bc3fc4ed8f4662bcb21bb3b8e6f3885497572810f7b53</citedby><cites>FETCH-LOGICAL-c3990-b3859fb034843ad820f7bc3fc4ed8f4662bcb21bb3b8e6f3885497572810f7b53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1600-0773.1993.tb00580.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1600-0773.1993.tb00580.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3876054$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7906879$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salonen, Markku</creatorcontrib><creatorcontrib>Maze, Mervyn</creatorcontrib><title>Implementation of a Radioreceptor Assay for Dexmedetomidine</title><title>Pharmacology &amp; toxicology</title><addtitle>Pharmacol Toxicol</addtitle><description>: We have implemented a radioreceptor assay for dexmedetomidine, a novel α2‐adrenoceptor agonist. Receptor‐bearing membranes were prepared from rat cerebral cortex and 3H‐clonidine, 4 nM, was used as the labeled ligand. Dexmedetomidine displaced 3H‐clonidine in a linear fashion over a concentration of 2 × 10‐10 to 2 × 10‐8 M. The detection limit of dexmedetomidine (i.e. 10% of radiolabeled ligand displaced) in this assay was 50 pg.ml‐1 which is comparable to that seen with the reference method which utilizes gas chromotography with mass spectrometer (GC/MS) in series (Vuorilehto et al. 1989). Endogenous catecholamines, which can displace the radiolabeled ligand from its binding site, could easily be eliminated with a one‐step extraction procedure. A comparison was made with the reference method (GC/MS) in 47 human plasma samples; the correlation coefficient (r2) was 0.61 (P&lt;0.001). The radioreceptor assay was also successfully applied for determining dexmedetomidine concentration in rabbit samples. These data indicate that the radioreceptor assay can be utilized for characterizing the pharmacokinetics of novel α2 agonists which are now being introduced into the clinical practice of anaesthesia.</description><subject>Adrenergic alpha-Agonists - analysis</subject><subject>Adrenergic alpha-Agonists - metabolism</subject><subject>Analysis</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cerebral Cortex - metabolism</subject><subject>Clonidine - metabolism</subject><subject>General pharmacology</subject><subject>Imidazoles - analysis</subject><subject>Imidazoles - metabolism</subject><subject>Male</subject><subject>Medetomidine</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Rabbits</subject><subject>Radioligand Assay - methods</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Adrenergic, alpha - metabolism</subject><issn>0901-9928</issn><issn>1600-0773</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkF1LwzAUhoMoc8z9BKGIeNeaNE2T6IXM-TUYKDKvQ5ImEOmXTYfbvzdlZffmJgfe5-ScPABcIZigcG6_E5RDGENKcYI4x0mvICQMJrsTMD1Gp2AKOUQx5yk7B3PvnYKYUIZQlk_AhHKYM8qn4H5VtaWpTN3L3jV11NhIRp-ycE1ntGn7posW3st9ZEP1ZHaVKUzfVK5wtbkAZ1aW3szHewa-Xp43y7d4_f66Wi7Wscacw1hhRrgN4zOWYVmwFFqqNLY6MwWzWZ6nSqsUKYUVM7nFjJGMU0JThgaS4Bm4Obzbds3P1vheVM5rU5ayNs3WC5qnGSIEBfDuAOqu8b4zVrSdq2S3FwiKQZ74FoMhMRgSgzwxyhO70Hw5Ttmq8Mtj66gq5NdjLr2Wpe1krZ0_YpjRHJIsYA8H7NeVZv-PBcTj8mMTKvwHvwCLKw</recordid><startdate>199311</startdate><enddate>199311</enddate><creator>Salonen, Markku</creator><creator>Maze, Mervyn</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199311</creationdate><title>Implementation of a Radioreceptor Assay for Dexmedetomidine</title><author>Salonen, Markku ; Maze, Mervyn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3990-b3859fb034843ad820f7bc3fc4ed8f4662bcb21bb3b8e6f3885497572810f7b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Adrenergic alpha-Agonists - analysis</topic><topic>Adrenergic alpha-Agonists - metabolism</topic><topic>Analysis</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cerebral Cortex - metabolism</topic><topic>Clonidine - metabolism</topic><topic>General pharmacology</topic><topic>Imidazoles - analysis</topic><topic>Imidazoles - metabolism</topic><topic>Male</topic><topic>Medetomidine</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Rabbits</topic><topic>Radioligand Assay - methods</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Adrenergic, alpha - metabolism</topic><toplevel>online_resources</toplevel><creatorcontrib>Salonen, Markku</creatorcontrib><creatorcontrib>Maze, Mervyn</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacology &amp; toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salonen, Markku</au><au>Maze, Mervyn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Implementation of a Radioreceptor Assay for Dexmedetomidine</atitle><jtitle>Pharmacology &amp; toxicology</jtitle><addtitle>Pharmacol Toxicol</addtitle><date>1993-11</date><risdate>1993</risdate><volume>73</volume><issue>5</issue><spage>254</spage><epage>256</epage><pages>254-256</pages><issn>0901-9928</issn><eissn>1600-0773</eissn><coden>PHTOEH</coden><abstract>: We have implemented a radioreceptor assay for dexmedetomidine, a novel α2‐adrenoceptor agonist. Receptor‐bearing membranes were prepared from rat cerebral cortex and 3H‐clonidine, 4 nM, was used as the labeled ligand. Dexmedetomidine displaced 3H‐clonidine in a linear fashion over a concentration of 2 × 10‐10 to 2 × 10‐8 M. The detection limit of dexmedetomidine (i.e. 10% of radiolabeled ligand displaced) in this assay was 50 pg.ml‐1 which is comparable to that seen with the reference method which utilizes gas chromotography with mass spectrometer (GC/MS) in series (Vuorilehto et al. 1989). Endogenous catecholamines, which can displace the radiolabeled ligand from its binding site, could easily be eliminated with a one‐step extraction procedure. A comparison was made with the reference method (GC/MS) in 47 human plasma samples; the correlation coefficient (r2) was 0.61 (P&lt;0.001). The radioreceptor assay was also successfully applied for determining dexmedetomidine concentration in rabbit samples. These data indicate that the radioreceptor assay can be utilized for characterizing the pharmacokinetics of novel α2 agonists which are now being introduced into the clinical practice of anaesthesia.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>7906879</pmid><doi>10.1111/j.1600-0773.1993.tb00580.x</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0901-9928
ispartof Pharmacology & toxicology, 1993-11, Vol.73 (5), p.254-256
issn 0901-9928
1600-0773
language eng
recordid cdi_proquest_miscellaneous_76241551
source MEDLINE; Wiley Journals Collection
subjects Adrenergic alpha-Agonists - analysis
Adrenergic alpha-Agonists - metabolism
Analysis
Animals
Biological and medical sciences
Cerebral Cortex - metabolism
Clonidine - metabolism
General pharmacology
Imidazoles - analysis
Imidazoles - metabolism
Male
Medetomidine
Medical sciences
Pharmacology. Drug treatments
Rabbits
Radioligand Assay - methods
Rats
Rats, Sprague-Dawley
Receptors, Adrenergic, alpha - metabolism
title Implementation of a Radioreceptor Assay for Dexmedetomidine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T14%3A03%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Implementation%20of%20a%20Radioreceptor%20Assay%20for%20Dexmedetomidine&rft.jtitle=Pharmacology%20&%20toxicology&rft.au=Salonen,%20Markku&rft.date=1993-11&rft.volume=73&rft.issue=5&rft.spage=254&rft.epage=256&rft.pages=254-256&rft.issn=0901-9928&rft.eissn=1600-0773&rft.coden=PHTOEH&rft_id=info:doi/10.1111/j.1600-0773.1993.tb00580.x&rft_dat=%3Cproquest_cross%3E76241551%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76241551&rft_id=info:pmid/7906879&rfr_iscdi=true